▲ Peaking
Business
AstraZeneca buys partner Omniose for bacterial vaccine technology
AstraZeneca has acquired preclinical biotechnology company Omniose to strengthen its bacterial vaccine pipeline.
1 trends tracked about this subject — the full history, oldest to newest below.
AstraZeneca has acquired preclinical biotechnology company Omniose to strengthen its bacterial vaccine pipeline.